dose for microdosing tirzepatide Tirzepatide Microdosing with Mounjaro KwikPens

Any claims about Omzo's non-GLP-1 programs should be verified directly at omzo.com before enrollment

Quick Answer: GLP-1 receptor agonists do not directly cause frequent urination as a pharmacological effect, though some patients may experience urinary changes due to indirect factors like weight loss, improved glycemic control, or hydration changes

Here is where the confusion starts

The bottom line: any significant change in how you feel after starting tirzepatide, whether matching hyper or hypothyroid patterns, should trigger a thyroid function test

1 Ozempic injection and Ozempic tablets are not approved for use in children